SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Matthias E. Liechti · Study

Home/Author

Matthias E. Liechti

47 works· latest 2023· 4 institutionscluster: provisionalORCID 0000-0002-1765-9659

h-index46

i1046

Citations8,757

Works here47

01

02

07

11

12

13

14

15

16

17

18

19

20

21

22

23

Most cited in this library

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers1998 · 448 citations
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects2014 · 411 citations
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation2017 · 400 citations
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens2016 · 377 citations
Gender differences in the subjective effects of MDMA2001 · 359 citations

Works

47 shown

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

Neuropsychopharmacology·2023·14 authors·Open access

129citations

Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants

Translational Psychiatry·2023·15 authors·Open access

89citations

Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants

Clinical Pharmacology & Therapeutics·2022·5 authors·Open access

120citations

Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants

The International Journal of Neuropsychopharmacology·2022·8 authors·Open access

104citations

Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study

Biological Psychiatry·2022·5 authors·Open access

316

citations

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology·2022·12 authors·Open access

225citations

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

Clinical Pharmacology & Therapeutics·2021·11 authors·Open access

184citations

Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study

European Neuropsychopharmacology·2020·9 authors·Open access

123citations

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects

Neuropsychopharmacology·2020·11 authors·Open access

242citations

Acute subjective effects in LSD- and MDMA-assisted psychotherapy

Journal of Psychopharmacology·2020·4 authors

85citations

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers

ACS Pharmacology & Translational Science·2020·11 authors·Open access

130citations

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Journal of Psychopharmacology·2020·9 authors·Open access

92citations

Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects

Neuropsychopharmacology·2019·9 authors·Open access

246citations

Altered network hub connectivity after acute LSD administration

NeuroImage Clinical·2018·5 authors·Open access

174citations

Increased thalamic resting‐state connectivity as a core driver of LSD‐induced hallucinations

Acta Psychiatrica Scandinavica·2017·7 authors·Open access

137citations

Long-lasting subjective effects of LSD in normal subjects

Psychopharmacology·2017·2 authors·Open access

232citations

Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects

Psychopharmacology·2017·5 authors·Open access

117citations

Modern Clinical Research on LSD

Neuropsychopharmacology·2017·1 author·review·Open access

235citations

Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects

Translational Psychiatry·2017·8 authors·Open access

127citations

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies

Journal of Psychopharmacology·2017·4 authors·Open access

89citations

Safety pharmacology of acute MDMA administration in healthy subjects

Journal of Psychopharmacology·2017·2 authors·Open access

146citations

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects

Clinical Pharmacokinetics·2017·7 authors·Open access

133citations

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Current Biology·2017·9 authors·Open access

400citations

Alterations of consciousness and mystical-type experiences after acute LSD in humans

Psychopharmacology·2016·3 authors·Open access

198citations

LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality

Neuropsychopharmacology·2016·5 authors·Open access

247citations

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

European Neuropsychopharmacology·2016·4 authors·Open access

377citations

Acute Effects of Lysergic Acid Diethylamide on Circulating Steroid Levels in Healthy Subjects

Journal of Neuroendocrinology·2016·8 authors

129citations

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs)

Neuropharmacology·2015·6 authors·Open access

217citations

Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans

The International Journal of Neuropsychopharmacology·2015·5 authors·Open access

112citations

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

Biological Psychiatry·2014·10 authors·Open access

411citations

Differential effects of MDMA and methylphenidate on social cognition

Journal of Psychopharmacology·2014·6 authors·Open access

155citations

Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination

The International Journal of Neuropsychopharmacology·2013·7 authors·Open access

126citations

MDMA enhances emotional empathy and prosocial behavior

Social Cognitive and Affective Neuroscience·2013·9 authors·Open access

356citations

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

PLoS ONE·2012·10 authors·Open access

157citations

Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans

British Journal of Pharmacology·2012·7 authors·Open access

82citations

MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions

Psychopharmacology·2012·3 authors

144citations

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

Clinical Pharmacology & Therapeutics·2011·8 authors

152citations

Decision Theory: What "Should" the Nervous System Do?

·2007·24 authors

0citations

Acute Psychological and Neurophysiological Effects of MDMA in Humans

Journal of Psychoactive Drugs·2002·5 authors

92citations

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies

Human Psychopharmacology Clinical and Experimental·2001·2 authors

236citations

Gender differences in the subjective effects of MDMA

Psychopharmacology·2001·3 authors

359citations

Effects of MDMA (Ecstasy) on Prepulse Inhibition and Habituation of Startle in Humans after Pretreatment with Citalopram, Haloperidol, or Ketanserin

Neuropsychopharmacology·2001·1 author

102citations

Psychological and Physiological Effects of MDMA (“Ecstasy”) after Pretreatment with the 5-HT2 Antagonist Ketanserin in Healthy Humans

Neuropsychopharmacology·2000·1 author

245citations

Acute psychological and physiological effects of MDMA (“Ecstasy”) after haloperidol pretreatment in healthy humans

European Neuropsychopharmacology·2000·2 authors

145citations

Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram

Neuropsychopharmacology·2000·1 author

248citations

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers

Journal of Psychopharmacology·2000·2 authors

144citations

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

Neuropsychopharmacology·1998·4 authors

448citations